back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-09 15:46 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-34,509 vol |
1,187 | |
| Filed 2025-04-09 15:45 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-966 vol |
33 | |
| Filed 2025-01-20 16:31 Tx date 2025-01-15 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,466 vol |
35,696 | |
| Filed 2025-01-15 11:38 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,001 vol |
999 | |
| Filed 2025-01-15 11:35 Tx date 2024-04-10 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-166 vol |
37,162 | |
| Filed 2023-08-18 13:26 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,000 vol |
||
| Filed 2024-02-08 09:53 Tx date 2024-02-05 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,333 vol |
37,328 | |
| Filed 2023-08-18 13:27 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-476,005 vol |
33,995 | |
| Filed 2023-08-18 13:26 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,000 vol |
1,000 | |
| Filed 2023-06-05 10:10 Tx date 2023-06-01 |
$MSCL
Satellos Bioscience Inc. |
Whitehead, Warren
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+246,869 vol |
448,389 | |
| Filed 2023-01-24 15:54 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
510,000 | |
| Filed 2022-10-06 17:27 Tx date 2022-10-06 |
$MSCL
Satellos Bioscience Inc. |
Whitehead, Warren
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
201,520 | |
| Filed 2022-01-20 18:34 Tx date 2022-01-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
410,000 | |
| Filed 2021-08-30 18:02 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Whitehead, Warren
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
131,520 | ||
| Filed 2021-06-23 17:24 Tx date 2021-06-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,419.20
-9,600 vol $4.00 each |
15,000 | |
| Filed 2021-06-23 17:22 Tx date 2021-06-21 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,848.40
-15,400 vol $4.15 each |
24,600 | |
| Filed 2021-01-06 19:54 Tx date 2021-01-04 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
360,000 | |
| Filed 2020-12-29 07:27 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,003
-10,000 vol $5.30 each |
40,000 | |
| Filed 2020-12-29 07:27 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-51,745
-10,000 vol $5.17 each |
50,000 | |
| Filed 2020-12-29 07:26 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$52,000
+20,000 vol $2.60 each |
60,000 | |
| Filed 2020-12-29 07:25 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-20,000 vol |
310,000 | |
| Filed 2020-06-29 08:53 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,000
-7,000 vol $9.00 each |
40,000 | |
| Filed 2020-06-29 08:53 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-46,100
-5,000 vol $9.22 each |
47,000 | |
| Filed 2020-06-29 08:52 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,590
-500 vol $9.18 each |
52,000 | |
| Filed 2020-06-29 08:51 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,929
-3,700 vol $9.17 each |
52,500 | |
| Filed 2020-06-29 08:51 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,320
-800 vol $9.15 each |
56,200 | |
| Filed 2020-06-29 08:50 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,640
+7,000 vol $3.52 each |
57,000 | |
| Filed 2020-06-29 08:50 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,899
+5,000 vol $1.38 each |
50,000 | |
| Filed 2020-06-29 08:49 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-95,500
-10,000 vol $9.55 each |
45,000 | |
| Filed 2020-06-29 08:48 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,920
-3,000 vol $9.64 each |
55,000 | |
| Filed 2020-06-29 08:47 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,450
-5,000 vol $9.69 each |
58,000 | |
| Filed 2020-06-29 08:47 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,200
+10,000 vol $1.52 each |
63,000 | |
| Filed 2020-06-29 08:46 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,125
+1,250 vol $5.70 each |
53,000 | |
| Filed 2020-06-29 08:46 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,080
+500 vol $2.16 each |
51,750 | |
| Filed 2020-06-29 08:45 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,225
+1,250 vol $2.58 each |
51,250 | |
| Filed 2020-06-29 08:44 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-7,000 vol |
330,000 | |
| Filed 2020-06-29 08:43 Tx date 2020-06-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,000 vol |
337,000 | |
| Filed 2020-06-29 08:42 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-10,000 vol |
342,000 | |
| Filed 2020-06-29 08:41 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-1,250 vol |
352,000 | |
| Filed 2020-06-29 08:41 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-500 vol |
353,250 | |
| Filed 2020-06-29 08:40 Tx date 2020-06-23 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-1,250 vol |
353,750 | |
| Filed 2020-03-14 13:48 Tx date 2020-03-11 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
355,000 | |
| Filed 2020-02-03 11:19 Tx date 2020-01-31 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+152,500 vol |
305,000 | |
| Filed 2019-01-03 Tx date 2019-01-02 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
152,500 | |
| Filed 2018-01-23 Tx date 2018-01-19 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
112,500 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,750
+5,000 vol $1.95 each |
50,000 | |
| Filed 2017-06-30 Tx date 2017-06-29 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,400
+10,000 vol $1.64 each |
45,000 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,000 vol |
35,000 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,000
+10,000 vol $1.60 each |
30,000 | |
| Filed 2017-06-30 Tx date 2017-06-27 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,670
+17,000 vol $1.51 each |
20,000 | |
| Filed 2017-06-30 Tx date 2017-06-27 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,519
+16,900 vol $1.51 each |
||
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,000 vol |
0 | |
| Filed 2017-06-09 Tx date 2017-06-06 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,899
+5,000 vol $1.38 each |
52,500 | |
| Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
47,500 | |
| Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
5,000 | |
| Filed 2017-03-31 Tx date 2011-04-07 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,200
+10,000 vol $3.82 each |
37,500 | |
| Filed 2015-12-16 Tx date 2011-04-07 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-16 Tx date 2015-12-15 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,802
+2,900 vol $3.38 each |
3,000 | |
| Filed 2015-12-16 Tx date 2015-12-15 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$333.00
+100 vol $3.33 each |
100 | |
| Filed 2015-12-07 Tx date 2015-08-06 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-07 Tx date 2015-12-07 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+50,000 vol $0.30 each |
50,000 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
150,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$20,750
+50,000 vol $0.415 each |
50,000 | |
| Filed 2015-09-14 Tx date 2015-08-06 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options common
00 - Opening Balance-Initial SEDI Report
|